Literature DB >> 12026229

White-matter alterations and callosal abnormalities in syndromic patients with mental retardation.

Orazio Gabrielli1, Stefano Bruni, Giovanni V Coppa, Ines Carloni, Gabriele Polonara, Luana Regnicolo, Simone Salvolini, Ugo Salvolini.   

Abstract

The aim of this study was to evaluate the frequency of callosal abnormalities and white matter alterations in syndromic patients. The authors report on the cerebral magnetic resonance imaging (MRI) morphologic analysis of the corpus callosum and white matter in 73 normal subjects and 61 syndromic patients. The study of the corpus callosum was carried out by MRI using different morphometric methods: measurement of the dimensions of length and thickness of genu, body, and splenium; measurement of angles obtained using the sagittal plane; and application of the proportional grid of Talairach. The evaluation of the white matter was carried out by applying a subjective grading scale. Abnormalities of the corpus callosum were found in about 50% of the syndromic subjects; in half of these cases, the abnormalities were associated with white matter alterations. In five syndromic patients (8.2%), the white matter alterations were not associated with corpus callosum abnormalities. This study shows that corpus callosum abnormalities are frequent in syndromology regardless of the syndrome type.

Entities:  

Mesh:

Year:  2002        PMID: 12026229     DOI: 10.1177/088307380201700302

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Unexplained mental retardation: is brain MRI useful?

Authors:  Fabrice Decobert; Sophie Grabar; Valerie Merzoug; Gabriel Kalifa; Gérard Ponsot; Catherine Adamsbaum; Vincent des Portes
Journal:  Pediatr Radiol       Date:  2005-03-01

2.  Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement.

Authors:  Lynn K Paul
Journal:  J Neurodev Disord       Date:  2010-09-23       Impact factor: 4.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.